BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30791232)

  • 41. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
    Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
    Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.
    Hong S; Yan Z; Wang H; Ding L; Bi M
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31350343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of microRNA-98 inhibits cell proliferation and promotes cell apoptosis via claudin-1 in human colorectal carcinoma.
    Zheng YF; Luo J; Gan GL; Li W
    J Cell Biochem; 2019 Apr; 120(4):6090-6105. PubMed ID: 30506722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer.
    Yao H; Xia D; Li ZL; Ren L; Wang MM; Chen WS; Hu ZC; Yi GP; Xu L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 29700213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial-mesenchymal transition underlying colorectal cancer exacerbation.
    Bai J; Xu J; Zhao J; Zhang R
    J Cell Physiol; 2020 Feb; 235(2):1453-1468. PubMed ID: 31276207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.
    Xia S; Wang X; Wu Y; Zhou T; Tian H; Liu Z; Li L; Yan Z; Zhang G
    Dis Markers; 2022; 2022():7843565. PubMed ID: 36061355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
    Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
    Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
    Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
    Fu X; Cui Y; Yang S; Xu Y; Zhang Z
    Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
    Chen Y; Liu Z; Wang H; Tang Z; Liu Y; Liang Z; Deng X; Zhao M; Fu Q; Li L; Cai H; Xie W; Fang W
    Int J Cancer; 2020 Jan; 146(2):496-509. PubMed ID: 31125123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non‑coding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Ai X; Lei Q; Shen X; Li J; Cen C; Xie G; Luo B; Zhu W; Hu G; Wu H; Chen M; Li X; Lin C
    Oncol Rep; 2019 Jan; 41(1):483-491. PubMed ID: 30542703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling.
    Gu C; Cai J; Xu Z; Zhou S; Ye L; Yan Q; Zhang Y; Fang Y; Liu Y; Tu C; Wang X; He J; Li Q; Han L; Lin X; Li A; Liu S
    Cell Death Dis; 2019 Sep; 10(10):739. PubMed ID: 31570702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Chen M; Lin M; Wang X
    Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.